Jian-jun Chen

Chongqing, 400016, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Lactobacillus johnsonii and 3-indolepropionic acid improve the depression-like behaviors via inhibiting neuroinflammation.

Lactobacillus johnsonii and 3-indolepropionic acid improve the depression-like behaviors via inhibiting neuroinflammation.

Journal: Pharmacological research

Published: January 23, 2026

Akkermansia muciniphila-derived SCFAs improve the depression-like behaviors of mice by inhibiting neuroinflammation.

Akkermansia muciniphila-derived SCFAs improve the depression-like behaviors of mice by inhibiting neuroinflammation.

Journal: Pharmacological research

Published: July 21, 2025

Fecal metabolites as early-phase biomarkers and prediction panel for ischemic stroke.

Fecal metabolites as early-phase biomarkers and prediction panel for ischemic stroke.

Journal: BMC microbiology

Published: January 30, 2025

Consistent decline of acetylcholine in microbiota-gut-brain axis mediates antibiotic-induced anxiety via regulating hippocampus microglial activation.

Consistent decline of acetylcholine in microbiota-gut-brain axis mediates antibiotic-induced anxiety via regulating hippocampus microglial activation.

Journal: Molecular psychiatry

Published: November 20, 2024

Multi-Omics Analysis Reveals Disturbances of Purine Metabolism and Glutamate Metabolism in the Hippocampus of Lipopolysaccharide-Induced Mouse Model of Depression.

Multi-Omics Analysis Reveals Disturbances of Purine Metabolism and Glutamate Metabolism in the Hippocampus of Lipopolysaccharide-Induced Mouse Model of Depression.

Journal: Brain and behavior

Published: November 17, 2024

Chronic administration of isotretinoin induces depressive- and anxiety-like behaviors by altering the neuroactive ligand-receptor interaction pathway in adolescent mice.

Chronic administration of isotretinoin induces depressive- and anxiety-like behaviors by altering the neuroactive ligand-receptor interaction pathway in adolescent mice.

Journal: Translational psychiatry

Published: September 11, 2024

Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder.

Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder.

Journal: Translational psychiatry

Published: November 01, 2023

Oral D-ribose causes depressive-like behavior by altering glycerophospholipid metabolism via the gut-brain axis.

Oral D-ribose causes depressive-like behavior by altering glycerophospholipid metabolism via the gut-brain axis.

Journal: Communications biology

Published: September 03, 2023

TCF4 and RBFOX1 as peripheral biomarkers for the differential diagnosis and treatment of major depressive disorder.

TCF4 and RBFOX1 as peripheral biomarkers for the differential diagnosis and treatment of major depressive disorder.

Journal: Journal of affective disorders

Published: April 26, 2023

LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study.

LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study.

Journal: Translational psychiatry

Published: January 09, 2023

Tryptophan metabolism as bridge between gut microbiota and brain in chronic social defeat stress-induced depression mice.

Tryptophan metabolism as bridge between gut microbiota and brain in chronic social defeat stress-induced depression mice.

Journal: Frontiers in cellular and infection microbiology

Published: December 12, 2022

Multi-omics data reveals the important role of glycerophospholipid metabolism in the crosstalk between gut and brain in depression.

Multi-omics data reveals the important role of glycerophospholipid metabolism in the crosstalk between gut and brain in depression.

Journal: Journal of translational medicine

Published: November 21, 2022

Showing 1-12 of 48

Last Updated: 09/26/2026